Serve as a key bridge between European commercial teams, customers, and internal departments.
Advance the market presence of immunology cell separation and cell therapy/reagent product lines across Europe through strategic market insights, commercial enablement, and expert technical support.
Enhance product understanding and application success with customers, while supporting internal teams with market intelligence.
Lead business development and sales activities across Europe for cell and gene therapy-related products and solutions.
Build and expand relationships with key stakeholders, including biotech companies, CDMOs, academic institutions, and core facilities.
Leverage your existing network to identify new opportunities and accelerate business growth.
GenScript Biotech Corporation is a global biotechnology group committed to making humans and nature healthier through biotechnology. Founded in 2002, GenScript has an established global presence across North America, Europe, the Greater China, and Asia Pacific and strives to be the most reliable biotech company in the world.
You will play a key role in driving business development and sales activities across Europe.
You will develop and execute a territory sales plan to achieve annual sales targets through new deal acquisition.
You will engage directly with prospective and existing clients, develop proposals that match target profiles, and communicate AGC Biologics’ capabilities effectively.
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) committed to delivering the highest standard of service. They employ more than 2,500 employees worldwide with a friendly, collaborative culture that values personal initiative and professional achievement.
Owning responsibility for assigned strategic accounts, driving expansion of bit.bio’s footprint.
Developing, implementing and executing global Senior Strategic Account strategies.
Driving revenue growth for the ioCells business while identifying additional revenue opportunities.
Bit.bio is an award-winning spinout from the University of Cambridge, combining synthetic and stem cell biology for the precise reprogramming of human cells used in research, drug discovery, and cell therapy. They are a team of individuals valuing science, collaboration, openness, curiosity and creativity.